Back to news overview

Ruth Devenyns new CEO of Camel-IDS

Camel-IDS, a privately held clinical stage radionuclide therapy company in oncology, has appointed Ruth Devenyns as Chief Executive Officer and director.

You can read the press article on VUB Today